Caswell-Jin, Jennifer L.

Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response

McNamara, K. L., Caswell-Jin, J. L., Joshi, R., Ma, Z., Kotler, E., Bean, G. R., Kriner, M., Zhou, Z., Hoang, M., Beechem, J., et al. (2020) · Nature Cancer

HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies

Cited by 92

First-in-human phase 1/2 dose escalation and expansion study evaluating first-in-class eIF4A inhibitor zotatifin in patients with solid tumors.

Meric-Bernstam, F., Sharma, M., Sommerhalder, D., Skeel, R. T., El-Khoueiry, A. B., Caswell-Jin, J. L., Patel, P. H., & Rosen, E. (2022) · Journal of Clinical Oncology

RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 17